180 Life Sciences Corp. (ATNF)

NASDAQ: ATNF · IEX Real-Time Price · USD

1.820

-0.010 (-0.55%)

At close: Apr 19, 2024, 3:51 PM

1.800

-0.020 (-1.10%)

After-hours: Apr 19, 2024, 4:25 PM EDT

180 Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Selling, General & Admin	10.69	15.47	11.69	3.36	5.89	0.6	0.34
Research & Development	2.78	2.43	3.95	2.29	2.04	0	0
Other Operating Expenses	0	0	0	0	12.93	0	0
Operating Expenses	13.48	17.9	15.64	5.65	20.86	0.6	0.34
Operating Income	-13.48	-17.9	-15.64	-5.65	-20.86	-0.6	-0.34
Interest Expense / Income	0.04	0.03	0.19	1.09	0.19	0	0
Other Expense / Income	8.76	21.74	4.52	4.17	4.36	-2.05	-0.66
Pretax Income	-22.28	-39.67	-20.35	-10.9	-25.4	1.45	0.32
Income Tax	-2.35	-0.94	-0.02	-0.02	-0.01	0.41	0.2
Net Income	-19.94	-38.73	-20.32	-10.88	-25.39	1.04	0.12
Preferred Dividends	0	0	0	1.12	0	0	0
Net Income Common	-19.94	-38.73	-20.32	-12.01	-25.39	1.04	0.12
Net Income Growth	-	-	-	-	-	740.75%	-
Shares Outstanding (Basic)	0	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0	0
Shares Change	279.01%	21.22%	72.72%	64.51%	-25.83%	57.68%	-
EPS (Basic)	-52.59	-387.18	-246.24	-250.80	-874.00	95.00	15.20
EPS (Diluted)	-52.59	-387.18	-246.24	-250.80	-874.00	26.60	3.80
EPS Growth	-	-	-	-	-	600.00%	-
Free Cash Flow	-10.92	-12.13	-19.37	-3.87	-3.32	-0.79	-0.5
Free Cash Flow Per Share	-28.81	-121.25	-234.76	-81.05	-114.28	-71.92	-54.77
Effective Tax Rate	-	-	-	-	-	28.42%	61.22%
EBITDA	-22.13	-39.53	-20.05	-9.69	-25.15	1.45	0.32
Depreciation & Amortization	0.11	0.11	0.11	0.13	0.07	0	0
EBIT	-22.24	-39.64	-20.16	-9.82	-25.22	1.45	0.32

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).